250 related articles for article (PubMed ID: 29216180)
1. The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity.
El-Athman R; Genov NN; Mazuch J; Zhang K; Yu Y; Fuhr L; Abreu M; Li Y; Wallach T; Kramer A; Schmitt CA; Relógio A
PLoS Biol; 2017 Dec; 15(12):e2002940. PubMed ID: 29216180
[TBL] [Abstract][Full Text] [Related]
2. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
3. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
4. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
5. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
6. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
7. Ras-mediated deregulation of the circadian clock in cancer.
Relógio A; Thomas P; Medina-Pérez P; Reischl S; Bervoets S; Gloc E; Riemer P; Mang-Fatehi S; Maier B; Schäfer R; Leser U; Herzel H; Kramer A; Sers C
PLoS Genet; 2014; 10(5):e1004338. PubMed ID: 24875049
[TBL] [Abstract][Full Text] [Related]
8. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
9. NONO couples the circadian clock to the cell cycle.
Kowalska E; Ripperger JA; Hoegger DC; Bruegger P; Buch T; Birchler T; Mueller A; Albrecht U; Contaldo C; Brown SA
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1592-9. PubMed ID: 23267082
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Randle DH; Zindy F; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
[TBL] [Abstract][Full Text] [Related]
11. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.
Barradas M; Anderton E; Acosta JC; Li S; Banito A; Rodriguez-Niedenführ M; Maertens G; Banck M; Zhou MM; Walsh MJ; Peters G; Gil J
Genes Dev; 2009 May; 23(10):1177-82. PubMed ID: 19451218
[TBL] [Abstract][Full Text] [Related]
13. INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform.
Tian X; Azpurua J; Ke Z; Augereau A; Zhang ZD; Vijg J; Gladyshev VN; Gorbunova V; Seluanov A
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1053-8. PubMed ID: 25550505
[TBL] [Abstract][Full Text] [Related]
14. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
Gilley J; Fried M
Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.
You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530
[TBL] [Abstract][Full Text] [Related]
16. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
[TBL] [Abstract][Full Text] [Related]
17. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
18. The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation.
Kuchenreuther MJ; Weber JD
Oncogene; 2014 Jan; 33(3):300-7. PubMed ID: 23318441
[TBL] [Abstract][Full Text] [Related]
19. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
